Today: 7 February 2026
Subscribe
Browse Category

NYSE:TMO News 9 January 2026 - 15 January 2026

Thermo Fisher (TMO) stock rises again as CEO points to U.S. reshoring contracts

Thermo Fisher (TMO) stock rises again as CEO points to U.S. reshoring contracts

New York, Jan 15, 2026, 13:00 ET — Regular session Thermo Fisher Scientific shares rose roughly 0.7% to hit $626.17 by midday Thursday, building on gains from the day before. CEO Marc Casper said Thermo Fisher’s pharmaceutical services have secured contracts to help clients move production from Europe and Asia back to the U.S. “There’s a very big focus on reshoring more production and activity to the U.S.,” he noted, calling it a tailwind for 2027 and 2028. Casper added that Thermo’s acquisition of Sanofi’s Ridgefield, New Jersey facility aims to boost capacity in support of this shift. (Reuters) Why
15 January 2026
·····
Thermo Fisher Scientific stock jumps on reshoring-contract talk, Nvidia tie-up as earnings loom

Thermo Fisher Scientific stock jumps on reshoring-contract talk, Nvidia tie-up as earnings loom

New York, Jan 14, 2026, 18:59 EST — After-hours Shares of Thermo Fisher Scientific climbed 2.4% to close at $621.83 on Wednesday, then held steady after hours. The stock fluctuated between $604.50 and $623.99 during the session, with roughly 2.46 million shares changing hands. This shift is significant since Thermo Fisher’s stock tends to reflect broader trends in lab demand and outsourcing spending, not merely its own financial results. With company leaders attending the J.P. Morgan Healthcare Conference and earnings approaching, investors are eager for any signs of more consistent orders heading into 2026. Chief Executive Marc Casper said Tuesday
15 January 2026
······
Thermo Fisher Scientific stock rises on reshoring contract talk, Nvidia lab deal and exec shuffle

Thermo Fisher Scientific stock rises on reshoring contract talk, Nvidia lab deal and exec shuffle

New York, Jan 14, 2026, 12:49 ET — Regular session Shares of Thermo Fisher Scientific (NYSE: TMO) climbed 1.4% to $615.46 Wednesday after CEO Marc Casper announced that the company’s pharma services division secured contracts linked to “reshoring” — shifting drug manufacturing back from Europe and Asia to the U.S. Speaking at the J.P. Morgan Healthcare Conference, Casper highlighted “a very big focus on reshoring” and noted that a delayed proposed 100% tariff on imported medicines has already prompted customers to accelerate projects and reconsider pricing. Evercore ISI analyst Vijay Kumar described the outlook as “constructive.” Casper also referenced Thermo’s
14 January 2026
·····
Thermo Fisher stock falls as CEO flags new U.S. reshoring contracts, Nvidia tie-up in focus

Thermo Fisher stock falls as CEO flags new U.S. reshoring contracts, Nvidia tie-up in focus

NEW YORK, Jan 13, 2026, 19:41 ET — After-hours trading Thermo Fisher Scientific’s pharmaceutical services unit has secured contracts to assist clients shifting drug manufacturing from Europe or Asia back to the U.S., CEO Marc Casper revealed Tuesday. Shares slipped 1.4% to close at $607.08. Casper highlighted a strong push toward reshoring production and operations to the U.S., calling it a boost for 2027 and 2028 as a proposed 100% tariff on imported medicines looms. (Reuters) These remarks are significant as investors seek clearer demand signals from life-science suppliers following a volatile period in biotech and pharma spending. For Thermo
14 January 2026
······
Thermo Fisher stock slides as Nvidia AI lab deal meets COO exit and March reshuffle

Thermo Fisher stock slides as Nvidia AI lab deal meets COO exit and March reshuffle

New York, Jan 13, 2026, 12:52 EST — Regular session Shares of Thermo Fisher Scientific dropped roughly 2% Tuesday, deepening a retreat in the life-sciences tools sector. The decline came despite the firm announcing a fresh strategic partnership with Nvidia and revealing some executive departures. The announcements arrive as investors hunt for clear demand drivers in lab equipment and services, a sector that often moves with capital spending cycles and drugmakers’ R&D budgets. The Nvidia connection also pulls Thermo Fisher into the market’s hottest theme — artificial intelligence — where traders usually price in potential upfront and debate the timing
13 January 2026
······
Thermo Fisher (TMO) stock slips after-hours after Nvidia lab-automation tie-up, exec shake-up

Thermo Fisher (TMO) stock slips after-hours after Nvidia lab-automation tie-up, exec shake-up

New York, Jan 12, 2026, 18:31 EST — After-hours Thermo Fisher Scientific Inc shares slipped roughly 0.5% in Monday’s after-hours session, following the life-sciences tools company’s announcement of a fresh partnership with Nvidia and a shake-up in its leadership team. The timing is crucial. Investors have rapidly backed any sign of renewed growth for lab suppliers following a rocky period in demand, particularly from biotech and pharma clients who keep a tight grip on budgets. It lands right in the thick of JPMorgan healthcare week, where executives and investors pack meetings hunting for clues on spending, backlog, and pricing. Thermo’s
13 January 2026
······
Thermo Fisher (TMO) stock slips after COO exit disclosed; AI lab deals put focus on JPM talk

Thermo Fisher (TMO) stock slips after COO exit disclosed; AI lab deals put focus on JPM talk

New York, Jan 12, 2026, 13:50 EST — Regular session Shares of Thermo Fisher Scientific dropped Monday following a regulatory filing revealing that its chief operating officer plans to exit later this quarter amid a reshuffle of the company’s senior leadership. The stock slipped 1.8% to $607.56, cooling off from an earlier high of $624.14. The management shake-up hits amid a hectic period for healthcare stocks, as investors seek clarity on biopharma budgets and lab equipment demand. Thermo Fisher, a key player in life-sciences tools, is pushing further into data and automation, areas that have been drawing steady interest throughout
12 January 2026
·····
Nvidia stock wobbles after $1B Eli Lilly AI lab plan as CPI and TSMC loom

Nvidia stock wobbles after $1B Eli Lilly AI lab plan as CPI and TSMC loom

NEW YORK, Jan 12, 2026, 10:43 a.m. ET — Regular session Nvidia (NVDA.O), the world’s most valuable listed company, and Eli Lilly (LLY.N) said on Monday they will spend $1 billion over five years on a joint research lab in the San Francisco Bay Area, betting Nvidia’s next Vera Rubin AI chips can speed drug discovery. Nvidia shares were down 0.2% at $184.42 by 10:30 a.m. ET. (Reuters) The move gives Nvidia another lane to sell chips and software as investors debate how long the AI spending surge by Big Tech can stay at full tilt. For Lilly, it is
12 January 2026
·······
Thermo Fisher stock rises as Stifel lifts target; JPM conference and Jan. 29 earnings in focus

Thermo Fisher stock rises as Stifel lifts target; JPM conference and Jan. 29 earnings in focus

New York, January 11, 2026, 15:15 EST — Market closed Thermo Fisher Scientific shares closed up on Friday, heading into the week with two key dates marked: a management update at the J.P. Morgan Healthcare Conference and the company’s quarterly earnings release later this month. The stock’s been bouncing between optimism over steady demand from biopharma clients and jitters about 2026 spending, as budgets reset with the new year. Stifel’s Daniel Arias bumped his price target on Thermo Fisher from $583 to $700, maintaining a buy rating. He expects the company to deliver a “solid year,” forecasting organic growth—excluding currency
11 January 2026
·····
Thermo Fisher Scientific Inc stock: Weaverville phase-out plan hits tape ahead of JPM talk, Jan. 29 earnings

Thermo Fisher Scientific Inc stock: Weaverville phase-out plan hits tape ahead of JPM talk, Jan. 29 earnings

New York, Jan 10, 2026, 15:53 EST — The market has closed. Thermo Fisher Scientific is set to wind down its Weaverville-area facility in western North Carolina, according to a WARN notice filed with the state. The document reveals permanent layoffs starting as early as Dec. 31, 2026, with the eventual closure slated for late 2027. The company plans to cut 421 jobs at its 275 Aiken Road site, beginning the first wave of separations at the end of 2026 and continuing through the following year. (WLOS) WARN, or Worker Adjustment and Retraining Notification, is a U.S. requirement for employers
10 January 2026
·····
Thermo Fisher (TMO) stock jumps as Stifel lifts target to $700; earnings next

Thermo Fisher (TMO) stock jumps as Stifel lifts target to $700; earnings next

New York, Jan 9, 2026, 19:08 EST — After-hours Thermo Fisher Scientific Inc (TMO.N) shares climbed roughly 2% on Friday following a price target boost from Stifel, which called for a “solid year” ahead as biopharma demand picked up. The stock ended the day up $12.45, closing at $618.86. (GuruFocus) The timing is crucial. Investors are gearing up for Thermo Fisher’s Q4 and full-year earnings, set for Jan. 29, when the company is likely to update its 2026 guidance. (Thermo Fisher Scientific) Coming up sooner, CEO Marc Casper will speak at the J.P. Morgan Healthcare Conference on Jan. 13. This
10 January 2026
·······
Thermo Fisher stock rises after Stifel lifts target to $700 as earnings near

Thermo Fisher stock rises after Stifel lifts target to $700 as earnings near

NEW YORK, Jan 9, 2026, 12:39 EST — Regular session Thermo Fisher Scientific (TMO.N) shares rose about 1.1% on Friday, recovering some ground after recent losses, after Stifel raised its price target on the life-sciences tools maker to $700 from $583 and kept a “Buy” rating. The stock was up $6.87 at $613.37 in midday trade. (GuruFocus) The call lands as investors start to look past last year’s choppy lab spending and ask what 2026 demand looks like, especially from biopharma customers that drive orders for instruments, consumables and contract services. This matters now because guidance, not the quarter, tends
9 January 2026
·····
1 2 3 4 5

Stock Market Today

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

Seagate (STX) stock jumps nearly 6% as Citi hikes target — what to watch next week

7 February 2026
Seagate shares rose 5.9% to $429.32 Friday after Citigroup raised its price target to $480 and reiterated a buy rating. The gain ended a two-day slide but left the stock 6.6% below its Feb. 3 high. CEO Dave Mosley sold 20,000 shares on Feb. 2 under a pre-arranged plan, SEC filings show. U.S. jobs and inflation data next week are seen as key tests for tech stocks.
Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

Cummins (CMI) stock price rebounds after earnings whipsaw as investors eye data-center power demand

7 February 2026
Cummins shares jumped 6.8% to $577.73 Friday, recovering from a nearly 9% post-earnings drop the day before. The company reported Q4 revenue up 1% to $8.54 billion, took a $218 million charge tied to its hydrogen business, and guided for 2026 EBITDA of 17–18% of sales. Demand for data center generators offset weakness in North American truck markets. Analyst reaction was mixed; Truist raised its price target.
Corning stock hits first record close since 2000 as jobs, CPI data loom

Corning stock hits first record close since 2000 as jobs, CPI data loom

7 February 2026
Corning shares surged 8.3% to $122.16 Friday, their highest close since the dot-com era, after Meta agreed to buy up to $6 billion in fiber-optic cables. The stock is up 40% since late 2025, fueled by strong first-quarter guidance and AI data-center demand. Insiders sold shares following the rally, SEC filings show. Investors await next week’s U.S. jobs and inflation data for rate signals.
Go toTop